2. Apoptosis
  3. RIP kinase Necroptosis
  4. RI-962

RI-962 是一种有效的选择性受体相互作用蛋白激酶 1 (RIPK1) 抑制剂。RI-962 抑制 RIPK1，IC50 值为 35.0 nM。RI-962 可用于神经系统疾病和炎症性疾病的研究。

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

RI-962

RI-962 Chemical Structure

CAS No. : 2763831-53-2

1.  客户无需承担相应的运输费用。

2.  同一机构（单位）同一产品试用装仅限申领一次，同一机构（单位）一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户。

规格 价格 是否有货 数量
1 mg ￥800
In-stock
5 mg ￥2000
In-stock
10 mg ￥3200
In-stock
50 mg   询价  
100 mg   询价  

* Please select Quantity before adding items.

Customer Review

RI-962 相关抗体

Top Publications Citing Use of Products

查看 RIP kinase 亚型特异性产品:

查看所有亚型
RIPK1 RIPK2 RIPK3

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

RI-962 is a potent and selective receptor-interacting protein kinase 1 (RIPK1) inhibitor. RI-962 inhibits RIPK1 with an IC50 value of 35.0 nM. RI-962 can be used for the research of nervous system diseases and inflammatory diseases[1].

IC50 & Target

IC50: 35.0 nM (RIPK1); EC50: 10.0 nM (HT29 cells), 4.2 nM (L929 cells), 11.4 nM (J774A.1 cells), 17.8 nM (U937 cells)[1].
体外研究
(In Vitro)

RI-962 对 RIPK1 具有强效抑制活性，IC50 值为 35.0 nM[1]。
RI-962 对坏死性凋亡具有保护作用，对 HT29、L929、J774A.1 和 U937 细胞的 EC50 值分别为 10.0 nM、4.2 nM、11.4 nM 和 17.8 nM[1]。
RI-962 (0-100 μM；24 小时) 通过抑制激酶来保护细胞免受 TSZ 诱导的坏死性凋亡RIPK1[1]的活性。

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

RI-962 相关抗体:

Cell Viability Assay[1]

Cell Line: HT29, L929, J774A.1, and U937 cells
Concentration: 0-100 μM
Incubation Time: 24 h
Result: Exerted a dose-dependent protective effect against necroptotic death.

Western Blot Analysis[1]

Cell Line: HT29 cells
Concentration: 0-400 nM
Incubation Time:
Result: Markedly inhibited the phosphorylation of RIPK1 and its downstream signaling proteins RIPK3 and MLKL in a dose-dependent manner.
体内研究
(In Vivo)

RI-962 (腹腔注射；40 mg/kg；每日一次，共 10 天) 可改善 TNFα 诱导的全身炎症反应综合征 (SIRS)，并减轻急性 DSS (HY-116282C) 诱导的结肠炎中的炎症[1]。
RI-962在大鼠体内的药代动力学参数（静脉注射、腹腔注射、口服；5、20 mg/kg）[1]。
Pharmacokinetic Parameters of RI-962 in rats (i.v., i.p., p.o.; 5, 20 mg/kg) [1].

RI-962 i.v. p.o. i.p.
Dose (mg/kg) 5 20 20
T1/2 (h) 2.1 ± 0.2 1.3 ± 0.2 8.5 ± 1.6
Tmax (h) 0.1 ± 0.0 0.8 ± 1.0 0.5 ± 0.0
Cmax (ng/mL) 12170.4 ± 1198.5 674.2 ± 424.7 3603.3 ± 693.3
AUC0-t(ng*h/mL) 4526.1 ± 546.0 1594.9 ± 891.8 6459.7 ± 1131.6
AUC0-∞ (ng*h/mL) 4538.1 ± 546.3 1604.5 ± 896.1 6609.3 ± 1121.4
Vss (L/kg) 0.4 ± 0.1 - -
MRT0-∞ (h) 0.4 ± 0.0 1.8 ± 0.2 2.8 ± 0.1
CL (mL/min/kg) 18.5 ± 2.1 - -
F (%) - 8.8 ± 5.0 35.7 ± 6.3

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: C57BL/6 female mice[1]
Dosage: 40 mg/kg
Administration: Intraperitoneal for 15 min; once a day for 10 day
Result: Ameliorated TNFα-induced SIRS by inhibiting RIPK1 activity.
Suppressed the RIPK1 signaling in the mouse model of DSS-induced colitis.
Animal Model: Sprague-Dawley (SD) rats[1]
Dosage: 5, 20 mg/kg
Administration: intravenous (i.v.) (5 mg/kg), intraperitoneal (i.p.) (20 mg/kg) and oral (p.o.) (20 mg/kg)
Result: Had good metabolic stability in rats.
分子量

480.56

Formula

C28H28N6O2
CAS 号
性状

固体

颜色

Off-white to light yellow

运输条件

Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
纯度 & 产品资料
参考文献

RI-962 相关分类

  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

RI-9622763831-53-2RI962RI 962RIP kinaseNecroptosisReceptor-interacting protein kinasesRIPKkinasesreceptor-interacting protein kinase 1 (RIPK1)nervous system diseasesinflammatory diseasesInhibitorinhibitorinhibit

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称：

  

* 需求量：

* 客户姓名：

 

* Email：

* 电话：

 

* 公司或机构名称：

   留言给我们：

Bulk Inquiry

Inquiry Information

产品名称：
RI-962
目录号：
HY-148382
需求量：

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

   产品名称：

  

* Lot #：

* 客户姓名：

 

* Email：

   电话：

 

* 部门：

* 公司或机构名称：

 

   留言给我们：

Request for HNMR Report

We have received your request and will respond to you as soon as possible.

嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z